Jane Street
BEAM icon

Jane Street’s Beam Therapeutics BEAM Stock Holding History

Jane Street’s Portfolio BEAM Stock Details BEAM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-310,010
Closed -$6.17M – 10781
2025
Q2 		$5.27M Buy
310,010
+185,843
+150% +$3.24M ﹤0.01% 2914
2025
Q1 		$2.42M Sell
124,167
-277,845
-69% -$7.28M ﹤0.01% 4056
2024
Q4 		$9.97M Buy
402,012
+213,921
+114% +$5.46M ﹤0.01% 1886
2024
Q3 		$4.61M Sell
188,091
-262,125
-58% -$6.77M ﹤0.01% 2995
2024
Q2 		$10.5M Buy
450,216
+278,399
+162% +$6.84M ﹤0.01% 1996
2024
Q1 		$5.68M Sell
171,817
-176,231
-51% -$5.49M ﹤0.01% 2453
2023
Q4 		$9.47M Buy
348,048
+331,890
+2,054% +$8.24M ﹤0.01% 2016
2023
Q3 		$389K Sell
16,158
-117,197
-88% -$3.14M ﹤0.01% 6658
2023
Q2 		$4.26M Buy
133,355
+92,210
+224% +$2.99M ﹤0.01% 2967
2023
Q1 		$1.26M Sell
41,145
-6,997
-15% -$276K ﹤0.01% 4594
2022
Q4 		$1.88M Buy
+48,142
New +$2.16M ﹤0.01% 3958
2022
Q3 		– Sell
-78,081
Closed -$4.45M – 9694
2022
Q2 		$3.02M Sell
78,081
-22,730
-23% -$904K ﹤0.01% 3428
2022
Q1 		$5.78M Buy
100,811
+79,982
+384% +$5.25M ﹤0.01% 2800
2021
Q4 		$1.66M Sell
20,829
-1,918
-8% -$164K ﹤0.01% 4853
2021
Q3 		$1.98M Sell
22,747
-33,955
-60% -$3.41M ﹤0.01% 4504
2021
Q2 		$7.3M Buy
56,702
+29,192
+106% +$2.33M ﹤0.01% 2098
2021
Q1 		$2.2M Buy
27,510
+3,486
+15% +$332K ﹤0.01% 3833
2020
Q4 		$1.96M Buy
+24,024
New +$1.18M ﹤0.01% 3516

Other funds holding BEAM

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
AVM
Arch Venture Management Chicago, Illinois $677M AUM 322.07% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return

Jane Street's BEAM Position: Q3 2025 in Review

Jane Street sold out of Beam Therapeutics (BEAM) in Q3 2025, closing a stake of 310,010 shares — an estimated $6.17M sold.

Jane Street first reported a position in BEAM in Q4 2020 and held it in 18 quarters. The position peaked at $10.5M in Q2 2024. 218 funds tracked by Wall St. Rank hold BEAM as of Q3 2025.

  • Jane Street reported no remaining Beam Therapeutics position as of Q3 2025 after selling out during the quarter.
  • Jane Street sold 310,010 Beam Therapeutics shares in Q3 2025, an estimated $6.17M.
  • Jane Street first reported a position in Beam Therapeutics in Q4 2020 and held it in 18 quarters.
  • Jane Street's Beam Therapeutics position peaked at $10.5M in Q2 2024.
  • 218 funds tracked by Wall St. Rank held Beam Therapeutics as of Q3 2025.

Based on Jane Street's 13F filing for Q3 2025, filed 14 Nov 2025.